Integrated Proteins Limited Fundamental Analysis (BSE: INTEGFD.BO)
Integrated Proteins Limited Fundamental Analysis (BSE: INTEGFD.BO)
Integrated Proteins Limited (BSE: INTEGFD.BO) shows weak financial fundamentals with a PE ratio of 598.57, profit margin of 2.69%, and ROE of 1.31%. The company generates $0.0B in annual revenue with N/A year-over-year growth of N/A.
Key Strengths
Areas of Concern
The stock receives a Fundamental Health Score of 41.7/100 based on profitability, valuation, growth, and balance sheet metrics. The D grade reflects weak fundamentals and significant financial concerns.
Fundamental Health Score
We analyze INTEGFD.BO's fundamental strength across five key dimensions:
Efficiency Score
WeakINTEGFD.BO struggles to generate sufficient returns from assets.
Valuation Score
ModerateINTEGFD.BO shows balanced valuation metrics.
Growth Score
ModerateINTEGFD.BO shows steady but slowing expansion.
Financial Health Score
ExcellentINTEGFD.BO maintains a strong and stable balance sheet.
Profitability Score
WeakINTEGFD.BO struggles to sustain strong margins.
Key Financial Metrics
Is INTEGFD.BO Expensive or Cheap?
P/E Ratio
INTEGFD.BO trades at 598.57 times earnings. This suggests a premium valuation.
PEG Ratio
When adjusting for growth, INTEGFD.BO's PEG of -8.63 indicates potential undervaluation.
Price to Book
The market values Integrated Proteins Limited at 12.95 times its book value. This suggests the stock is fully valued or overvalued on an asset basis.
EV/EBITDA
Enterprise value stands at 148.30 times EBITDA. This signals the market has high growth expectations.
How Well Does INTEGFD.BO Make Money?
Net Profit Margin
For every $100 in sales, Integrated Proteins Limited keeps $2.69 as profit after all expenses.
Operating Margin
Core operations generate 2.55 in profit for every $100 in revenue, before interest and taxes.
ROE
Management delivers $1.31 in profit for every $100 of shareholder equity.
ROA
Integrated Proteins Limited generates $1.29 in profit for every $100 in assets, demonstrating efficient asset deployment.
Following the Money - Real Cash Generation
Operating Cash Flow
Integrated Proteins Limited generates limited operating cash flow of $0.00, signaling weaker underlying cash strength.
Free Cash Flow
Integrated Proteins Limited generates weak or negative free cash flow of $0.00, restricting financial flexibility.
FCF Per Share
Each share generates $0.00 in free cash annually.
FCF Yield
INTEGFD.BO converts 0.00% of its market value into free cash.
Financial Ratios Analysis
Valuation Ratios
P/E Ratio
Price to earnings ratio
598.57
vs 25 benchmark
PEG Ratio
Price/earnings to growth ratio
-8.63
vs 25 benchmark
P/B Ratio
Price to book value ratio
12.95
vs 25 benchmark
P/S Ratio
Price to sales ratio
4.59
vs 25 benchmark
Financial Health
Debt/Equity
Total debt to shareholders' equity
0.00
vs 25 benchmark
Current Ratio
Current assets to current liabilities
244.23
vs 25 benchmark
Efficiency Ratios
ROE
Return on equity percentage
0.01
vs 25 benchmark
ROA
Return on assets percentage
0.01
vs 25 benchmark
ROCE
Return on capital employed
0.01
vs 25 benchmark
How INTEGFD.BO Stacks Against Its Sector Peers
| Metric | INTEGFD.BO Value | Sector Average | Performance |
|---|---|---|---|
| P/E Ratio | 598.57 | 29.34 | Worse (Expensive) |
| ROE | 1.31% | 1104.00% | Weak |
| Net Margin | 2.69% | -25189.00% (disorted) | Weak |
| Debt/Equity | 0.00 | 0.95 | Strong (Low Leverage) |
| Current Ratio | 244.23 | 21.76 | Strong Liquidity |
| ROA | 1.29% | -1328228.00% (disorted) | Weak |
INTEGFD.BO outperforms its industry in 2 out of 6 key metrics, but lagging in P/E Ratio.
Historical Growth Performance
5-Year Growth Trajectory
This section reviews Integrated Proteins Limited's 5-year compound annual growth rate (CAGR) and compares its performance against the typical investment style of its industry.
Revenue CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
EPS CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure
FCF CAGR
N/A
Industry Style: Cyclical, Value, Infrastructure